Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older

CONCLUSIONS: TBE vaccine elicited robust immune responses in Japanese participants 1 year of age and older. The 3-dose regimen was safe and well tolerated, and findings were consistent with the known safety profile of this TBE vaccine.CLINICALTRIALS: gov: NCT04648241.PMID:38614954 | DOI:10.1016/j.vaccine.2024.03.071

Source: Vaccine - April 13, 2024 Category: Allergy & Immunology Authors: Motoharu Yonekawa Tohru Watanabe Osamu Kogawara Chihiro Yoshii Masako Yamaji Masakazu Aizawa Wilhelm Erber Shuhei Ito Bogdan Jug Doris Koelch Richard de Solom Stephen P Lockhart Source Type: research